Jean Coutu Group (PJC) (A) (PJC.A.TO)

HOLD

Prefers Shoppers (SC-T) but both companies have the same problem. The government is squeezing them on the prescription side. Both are in the same business and the same kind of model.

DON'T BUY

Thought it would have grown a little bit faster after they had sold off some unsuccessful businesses. Has been kind of sitting around $15. He is kind of getting a little bit bored with this.

PAST TOP PICK

(A Top Pick Nov 15/11. Up 16.22%.) Sold his holdings in August for gain of over 30% from his original cost price. Felt that for the time being consumer staples were not going to do as well but since then some of them are starting to look interesting. If you own, continue to Hold. $14.50 would be an ideal entry point.

PAST TOP PICK

(Top Pick Aug 8/11, Up 29.30%) Squeezed everything he could out of it. Some of the other names were screaming more. Weston and Loblaws. If it breaks to new highs he will buy it back.

PAST TOP PICK
(A Top Pick July 6/11. Up 32.5%.) Chart shows a very long term trend. He has a stop below $14.50.
TOP PICK
Drugstore chain, primarily in Québec and New Brunswick. Had some issues where they had bought some Rite Aid stores and are getting this sorted out. Expect the cash they get from selling these will be used for a domestic acquisition. Managing the balance sheet well. Very undervalued.
TOP PICK
Had a strong quarterly report and are in a strong long-term trend. He would put a Stop in at around $13.75. They're in the right space in Consumer Staples, which is strong in Canada and the US on a monthly and weekly basis.
TOP PICK
Very good return on equity. Very good valuation. Very undervalued.
SELL
It never hurts to take profits when you have them. IN the drug retail trade, Alberta is going to review their drug reimbursement as did Ontario in the past. But this one has things going well, same store sales going up. They have retrenched from the bad experience in the US and done better. Multiples are not that huge. If you are really long term focused, they will do ok, but after this run he would be tempted to take profits.
DON'T BUY
Another dual class share company, which disqualifies it with him. Pretty well run drug store chain. Got into trouble years ago with a US acquisition and ended up selling to RightAid.
DON'T BUY
Has gone a long way to straightening out some of the difficulties they were having in the US. Still own a little bit of Rite Aid but have been fixing in terms of monetizing in order to reduce their exposure. All the alien drug companies have been faced with provinces’ handling of generic drugs. Last quarter was a little bit weak. Same-store sales were okay but margins on some of the sundry items were not as high as he would have liked. This is reflective of the competitive environment out there. He would prefer Shoppers (SC-T).
TOP PICK
It is trending up. Broke out of $12.50 level. Did a good job of strengthening their brand. He would be adding to it right here.
TOP PICK
Likes it better than shoppers. Last earnings were pretty good, beating estimates. Executed well.
TOP PICK
Consumer staples is a good place to be in the summer. Also a good place to be if we have a lower growth environment. Sales were up in nonprescription drugs by 6%. Executing really well.
TOP PICK
Consumers staples is the right space at this time. Good upward trend line and has broken through its resistance. Decent volume. Good earnings.
Showing 31 to 45 of 204 entries